Advertisement

Topics

Search Results for "Pharmac Cost Of Sativex In New Zealand"

23:36 EDT 5th May 2016 | BioPortfolio

Matching Channels

Marginal cost

TASH Biotechnology

Shanghai TASH Biotechnology Co.,Ltd. specializes in peptide development on the basis of high technology. TASH Biotechnology are focusing on custom peptide synthesis, and the research, development...

CaptureSelect

BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biop...

CombiCult

CombiCult® is an award winning, combinatorial screening technology that allows scientists to discover new and improved stem cell differentiation protocols. How Combicult® works A short o...

Latin America

Latin America encompasses the Caribbean, South America and Central America. These countries are important players in the biotechnology industry, not only as consumers, but as contributors. The env...

Matching News

PHARMAC proposes listing of Harvoni and Viekira Pak

New Zealand’s Pharmaceutical Management Agency PHARMAC is seeking feedback on two proposals to list…

NZ’s PHARMAC calls for proposals on insulin glargine supplies

New Zealand’s Pharmaceutical Management Agency, PHARMAC, this morning announced is interested in considering…

NZ’s PHARMAC considers listing of Amgen’s Sensipar

New Zealand’s Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to list cinacalcet…

NZ’s PHARMAC to fund Sensipar; consult on Sirturo, Sylvant

New Zealand’s Pharmaceutical Management Agency PHARMAC announced today its decision to list cinacalcet…

Medicines New Zealand says PHARMAC model needs updating

“We are outraged that the Minister of Health has today confirmed NZ$30 million [~$20 million] of PHARMAC’s…

PHARMAC proposal to list new respiratory products

New Zealand’s Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to relating…

New Zealand to list BioMarin’s Naglazyme for mucopolysaccharidosis VI

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

Asacol 800mg tablets approved for funding in New Zealand

New Zealand’s Pharmaceutical Management Agency, PHARMAC, has announce the approval of an agreement…

Matching PubMed Articles

Uptake of new medicines: the Pharmaceutical Management Agency of New Zealand (PHARMAC) in the international context.

New Zealand patients.

Objective The aim of the present study was to better understand the views and experiences of New Zealand patients on switching between brands of prescription medicines and on alternative funding optio...

Is cost-related non-collection of prescriptions associated with a reduction in health? Findings from a large-scale longitudinal study of New Zealand adults.

To investigate whether cost-related non-collection of prescription medication is associated with a decline in health.

HIV-associated tuberculosis in Auckland.

New Zealand has low rates of disease caused by to Mycobacterium tuberculosis (TB) and Human Immunodeficiency Virus (HIV). This study is the first to describe a New Zealand cohort of patients with HIV-...

Exploring the success of Good Samaritan organ donation in New Zealand.

The rate of living kidney donation from 2006 to 2012 was roughly the same in Australia and New Zealand, but the rate of Good Samaritan donation was significantly higher in New Zealand (1.49 donors/mil...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement